US Stock MarketDetailed Quotes

ABVC ABVC BioPharma

Watchlist
  • 0.5102
  • +0.0042+0.83%
Close Nov 27 16:00 ET
  • 0.5061
  • -0.0041-0.80%
Post 20:02 ET
6.62MMarket Cap-629P/E (TTM)

ABVC BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
2,350.74%389.28K
1,817.53%117.14K
-99.06%1.21K
-84.28%152.43K
-99.63%2.17K
-62.42%15.88K
-98.05%6.11K
399.89%128.27K
172.57%969.78K
1,658.47%588.99K
Operating revenue
2,350.74%389.28K
1,817.53%117.14K
-99.06%1.21K
-84.28%152.43K
-99.63%2.17K
-62.42%15.88K
-98.05%6.11K
399.89%128.27K
172.57%969.78K
1,658.47%588.99K
Cost of revenue
-99.00%296
-99.74%190
-99.54%277
5.45%302.04K
-47.55%139.21K
175.71%29.61K
772.25%72.98K
3,077.00%60.24K
5,531.44%286.42K
9,372.20%265.41K
Gross profit
2,933.07%388.98K
274.89%116.95K
-98.64%928
-121.89%-149.61K
-142.35%-137.04K
-143.55%-13.73K
-121.96%-66.87K
186.30%68.04K
94.85%683.37K
897.10%323.58K
Operating expense
-84.17%339.03K
-48.58%1.09M
74.52%3.45M
-48.94%8.07M
-47.21%1.82M
-42.86%2.14M
-9.54%2.13M
-68.37%1.97M
35.07%15.8M
-45.15%3.46M
Selling and administrative expenses
-84.94%301.21K
-34.69%1.05M
105.96%3.38M
-46.55%7M
-10.63%1.75M
-41.90%2M
-11.33%1.61M
-72.14%1.64M
18.56%13.1M
-68.10%1.96M
-General and administrative expense
-84.94%301.21K
-34.69%1.05M
105.96%3.38M
-46.55%7M
-10.63%1.75M
-41.90%2M
-11.33%1.61M
-72.14%1.64M
18.56%13.1M
-68.10%1.96M
Research and development costs
-73.23%37.83K
-92.15%40.4K
-79.38%69.07K
-60.54%1.06M
-95.17%72.19K
-53.74%141.31K
-3.44%514.44K
-6.80%334.98K
168.32%2.69M
474.89%1.5M
Operating profit
102.32%49.95K
55.48%-976.64K
-80.70%-3.44M
45.64%-8.22M
37.39%-1.96M
42.01%-2.15M
-7.18%-2.19M
69.35%-1.91M
-33.22%-15.11M
50.61%-3.13M
Net non-operating interest income expense
85.13%-175.27K
-290.03%-232.89K
-17,122.52%-680.63K
-2,074.13%-2.31M
-1,340.33%-1.07M
-1,403.57%-1.18M
-346.16%-59.71K
-117.99%-3.95K
42.31%-106.15K
-1,373.77%-74K
Non-operating interest income
9.98%44.26K
-50.69%27.14K
-92.32%4.05K
-1.24%185.48K
-38.01%37.48K
-16.44%40.25K
41.08%55.04K
31.20%52.71K
334.80%187.82K
305.74%60.46K
Non-operating interest expense
-81.99%219.53K
126.60%260.03K
1,108.34%684.68K
748.17%2.49M
720.54%1.1M
863.07%1.22M
677.56%114.75K
211.11%56.66K
29.38%293.97K
651.82%134.46K
Other net income (expense)
76.02%-8.59K
-969.26%-174.05K
1,015.80%144.01K
55.82%-129.91K
61.63%-127.02K
-263.52%-35.83K
378.83%20.02K
-42.07%12.91K
-192.39%-294.03K
-172.29%-331.04K
Gain on sale of security
221.43%30.43K
-542.80%-117.67K
1,025.86%113.52K
25.37%-199.2K
49.58%-143.57K
-14,057.63%-25.06K
-274.68%-18.31K
-262.12%-12.26K
-270.58%-266.91K
-179.01%-284.77K
Earnings from equity interest
---67.89K
---79.06K
----
----
----
--0
--0
----
----
----
Special income (charges)
----
----
----
--0
----
----
----
----
---110.13K
----
-Write off
----
----
----
--0
----
----
----
----
--110.13K
----
Other non- operating income (expenses)
368.03%28.86K
-40.85%22.67K
21.13%30.49K
-16.53%69.28K
-74.07%16.56K
-148.75%-10.77K
317.03%38.33K
71.04%25.17K
-48.70%83K
-34.53%63.86K
Income before tax
96.03%-133.92K
38.05%-1.38M
-109.83%-3.98M
31.33%-10.65M
10.84%-3.15M
10.69%-3.37M
-10.04%-2.23M
69.27%-1.9M
-38.39%-15.51M
39.93%-3.54M
Income tax
135.54%355
-235.74%-110.89K
0
-67.91%256.01K
-81.79%175.31K
-123.66%-999
199.08%81.7K
0
-3.30%797.78K
-4.79%962.87K
Net income
96.01%-134.27K
45.03%-1.27M
-109.83%-3.98M
33.12%-10.91M
26.02%-3.33M
10.82%-3.37M
-18.89%-2.32M
68.83%-1.9M
-35.53%-16.31M
34.78%-4.5M
Net income continuous Operations
96.01%-134.27K
45.03%-1.27M
-109.83%-3.98M
33.12%-10.91M
26.02%-3.33M
10.82%-3.37M
-18.89%-2.32M
68.83%-1.9M
-35.53%-16.31M
34.78%-4.5M
Minority interest income
203.41%52.29K
-402.85%-260.04K
34.67%-48.04K
-455.96%-394.63K
-160.27%-218.82K
29.44%-50.56K
41.46%-51.71K
20.22%-73.54K
-86.19%110.87K
-64.79%363.04K
Net income attributable to the parent company
94.38%-186.56K
55.26%-1.01M
-115.66%-3.93M
35.97%-10.52M
36.04%-3.11M
10.46%-3.32M
-21.76%-2.26M
69.58%-1.82M
-27.92%-16.42M
38.68%-4.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
94.38%-186.56K
55.26%-1.01M
-115.66%-3.93M
35.97%-10.52M
36.04%-3.11M
10.46%-3.32M
-21.76%-2.26M
69.58%-1.82M
-27.92%-16.42M
38.68%-4.86M
Basic earnings per share
97.56%-0.02
86.76%-0.09
27.27%-0.4
53.18%-2.43
73.44%-0.3931
28.07%-0.82
-15.25%-0.68
72.50%-0.55
-1.76%-5.19
52.26%-1.48
Diluted earnings per share
97.56%-0.02
86.76%-0.09
27.27%-0.4
53.18%-2.43
73.44%-0.3931
28.07%-0.82
-15.25%-0.68
72.50%-0.55
-1.76%-5.19
52.26%-1.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 2,350.74%389.28K1,817.53%117.14K-99.06%1.21K-84.28%152.43K-99.63%2.17K-62.42%15.88K-98.05%6.11K399.89%128.27K172.57%969.78K1,658.47%588.99K
Operating revenue 2,350.74%389.28K1,817.53%117.14K-99.06%1.21K-84.28%152.43K-99.63%2.17K-62.42%15.88K-98.05%6.11K399.89%128.27K172.57%969.78K1,658.47%588.99K
Cost of revenue -99.00%296-99.74%190-99.54%2775.45%302.04K-47.55%139.21K175.71%29.61K772.25%72.98K3,077.00%60.24K5,531.44%286.42K9,372.20%265.41K
Gross profit 2,933.07%388.98K274.89%116.95K-98.64%928-121.89%-149.61K-142.35%-137.04K-143.55%-13.73K-121.96%-66.87K186.30%68.04K94.85%683.37K897.10%323.58K
Operating expense -84.17%339.03K-48.58%1.09M74.52%3.45M-48.94%8.07M-47.21%1.82M-42.86%2.14M-9.54%2.13M-68.37%1.97M35.07%15.8M-45.15%3.46M
Selling and administrative expenses -84.94%301.21K-34.69%1.05M105.96%3.38M-46.55%7M-10.63%1.75M-41.90%2M-11.33%1.61M-72.14%1.64M18.56%13.1M-68.10%1.96M
-General and administrative expense -84.94%301.21K-34.69%1.05M105.96%3.38M-46.55%7M-10.63%1.75M-41.90%2M-11.33%1.61M-72.14%1.64M18.56%13.1M-68.10%1.96M
Research and development costs -73.23%37.83K-92.15%40.4K-79.38%69.07K-60.54%1.06M-95.17%72.19K-53.74%141.31K-3.44%514.44K-6.80%334.98K168.32%2.69M474.89%1.5M
Operating profit 102.32%49.95K55.48%-976.64K-80.70%-3.44M45.64%-8.22M37.39%-1.96M42.01%-2.15M-7.18%-2.19M69.35%-1.91M-33.22%-15.11M50.61%-3.13M
Net non-operating interest income expense 85.13%-175.27K-290.03%-232.89K-17,122.52%-680.63K-2,074.13%-2.31M-1,340.33%-1.07M-1,403.57%-1.18M-346.16%-59.71K-117.99%-3.95K42.31%-106.15K-1,373.77%-74K
Non-operating interest income 9.98%44.26K-50.69%27.14K-92.32%4.05K-1.24%185.48K-38.01%37.48K-16.44%40.25K41.08%55.04K31.20%52.71K334.80%187.82K305.74%60.46K
Non-operating interest expense -81.99%219.53K126.60%260.03K1,108.34%684.68K748.17%2.49M720.54%1.1M863.07%1.22M677.56%114.75K211.11%56.66K29.38%293.97K651.82%134.46K
Other net income (expense) 76.02%-8.59K-969.26%-174.05K1,015.80%144.01K55.82%-129.91K61.63%-127.02K-263.52%-35.83K378.83%20.02K-42.07%12.91K-192.39%-294.03K-172.29%-331.04K
Gain on sale of security 221.43%30.43K-542.80%-117.67K1,025.86%113.52K25.37%-199.2K49.58%-143.57K-14,057.63%-25.06K-274.68%-18.31K-262.12%-12.26K-270.58%-266.91K-179.01%-284.77K
Earnings from equity interest ---67.89K---79.06K--------------0--0------------
Special income (charges) --------------0-------------------110.13K----
-Write off --------------0------------------110.13K----
Other non- operating income (expenses) 368.03%28.86K-40.85%22.67K21.13%30.49K-16.53%69.28K-74.07%16.56K-148.75%-10.77K317.03%38.33K71.04%25.17K-48.70%83K-34.53%63.86K
Income before tax 96.03%-133.92K38.05%-1.38M-109.83%-3.98M31.33%-10.65M10.84%-3.15M10.69%-3.37M-10.04%-2.23M69.27%-1.9M-38.39%-15.51M39.93%-3.54M
Income tax 135.54%355-235.74%-110.89K0-67.91%256.01K-81.79%175.31K-123.66%-999199.08%81.7K0-3.30%797.78K-4.79%962.87K
Net income 96.01%-134.27K45.03%-1.27M-109.83%-3.98M33.12%-10.91M26.02%-3.33M10.82%-3.37M-18.89%-2.32M68.83%-1.9M-35.53%-16.31M34.78%-4.5M
Net income continuous Operations 96.01%-134.27K45.03%-1.27M-109.83%-3.98M33.12%-10.91M26.02%-3.33M10.82%-3.37M-18.89%-2.32M68.83%-1.9M-35.53%-16.31M34.78%-4.5M
Minority interest income 203.41%52.29K-402.85%-260.04K34.67%-48.04K-455.96%-394.63K-160.27%-218.82K29.44%-50.56K41.46%-51.71K20.22%-73.54K-86.19%110.87K-64.79%363.04K
Net income attributable to the parent company 94.38%-186.56K55.26%-1.01M-115.66%-3.93M35.97%-10.52M36.04%-3.11M10.46%-3.32M-21.76%-2.26M69.58%-1.82M-27.92%-16.42M38.68%-4.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 94.38%-186.56K55.26%-1.01M-115.66%-3.93M35.97%-10.52M36.04%-3.11M10.46%-3.32M-21.76%-2.26M69.58%-1.82M-27.92%-16.42M38.68%-4.86M
Basic earnings per share 97.56%-0.0286.76%-0.0927.27%-0.453.18%-2.4373.44%-0.393128.07%-0.82-15.25%-0.6872.50%-0.55-1.76%-5.1952.26%-1.48
Diluted earnings per share 97.56%-0.0286.76%-0.0927.27%-0.453.18%-2.4373.44%-0.393128.07%-0.82-15.25%-0.6872.50%-0.55-1.76%-5.1952.26%-1.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data